The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3,6-dioxo-4-(2-(pyrrolidin-1-yl)ethylamino)cyclohexa-1,4-dienyl)benzamide ID: ALA4093359
PubChem CID: 132576256
Max Phase: Preclinical
Molecular Formula: C19H21N3O3
Molecular Weight: 339.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1C=C(NC(=O)c2ccccc2)C(=O)C=C1NCCN1CCCC1
Standard InChI: InChI=1S/C19H21N3O3/c23-17-13-16(21-19(25)14-6-2-1-3-7-14)18(24)12-15(17)20-8-11-22-9-4-5-10-22/h1-3,6-7,12-13,20H,4-5,8-11H2,(H,21,25)
Standard InChI Key: XFVYQRRKFPURLP-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
16.8886 -10.2974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8886 -11.1146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5939 -11.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2992 -11.1146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2992 -10.2974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5939 -9.8847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5939 -9.0675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5939 -12.3363 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0081 -9.8909 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7146 -10.3016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4235 -9.8951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7122 -11.1188 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1815 -11.5242 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4732 -11.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7661 -11.5263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0578 -11.1187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9668 -10.3072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1672 -10.1384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7596 -10.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3073 -11.4532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1267 -10.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8352 -9.9035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8380 -9.0854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1265 -8.6749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4210 -9.0831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
3 8 2 0
5 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
2 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
11 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 11 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.40Molecular Weight (Monoisotopic): 339.1583AlogP: 1.02#Rotatable Bonds: 6Polar Surface Area: 78.51Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.26CX Basic pKa: 7.39CX LogP: 1.24CX LogD: 0.95Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: -0.43
References 1. Nain-Perez A, Barbosa LC, Rodríguez-Hernández D, Kramell AE, Heller L, Csuk R.. (2017) Natural abenquines and synthetic analogues: Preliminary exploration of their cytotoxic activity., 27 (5): [PMID:28169163 ] [10.1016/j.bmcl.2017.01.079 ]